Canine cutaneous melanocytic tumours: significance of β‐catenin and survivin immunohistochemical expression
- 12 May 2015
- journal article
- Published by Wiley in Veterinary Dermatology
- Vol. 26 (4) , 270-e59
Abstract
Recent investigations have highlighted the controversial role of Wnt/β-catenin pathway activation in human cutaneous melanoma. Survivin has been proposed as a valid prognostic marker for invasive and metastatic melanomas and lymph node melanoma metastasis in human cutaneous melanoma and is a promising therapeutic target. Our aim was to investigate the immunohistochemical expression of survivin and β-catenin in canine cutaneous melanocytic tumours, in order to understand their prognostic significance. Twenty-one melanocytic tumours (10 melanocytomas and 11 melanomas) were investigated by immunohistochemistry using specific anti-survivin and anti-β-catenin antibodies. A semi-quantitative method was used to analyse the results; β-catenin immunolabelling in neoplastic cells was evaluated as cytoplasmic, membranous or nuclear. The number of survivin-positive cells was counted within ~1000 neoplastic cells. Results were related to histopathological features, evaluated in haematoxylin- and eosin-stained slides, and to the clinical data obtained through a telephone survey with referring veterinarians. Despite a low level of expression in the majority of cases, β-catenin was found to be correlated strongly with malignant behaviour (P < 0.01). An overexpression of nuclear survivin was statistically related to histological features of malignancy, presence of metastasis and death related to melanoma spread (P < 0.01). The low nuclear β-catenin expression, mainly found in metastatic cases, would indicate that β-catenin activation may have only limited importance in the development or progression of canine cutaneous melanoma. The correlation of nuclear survivin expression with malignancy would indicate that survivin is possibly a useful prognostic marker and therapeutic target in canine melanoma patients.Keywords
This publication has 52 references indexed in Scilit:
- KIT gene exon 11 mutations in canine malignant melanomaThe Veterinary Journal, 2013
- Study of c-kit immunoexpression in canine cutaneous melanocytic tumorsMelanoma Research, 2012
- Evaluation of tyrosinase expression in canine and equine melanocytic tumorsAmerican Journal of Veterinary Research, 2012
- Prognostic Markers for Canine Melanocytic NeoplasmsVeterinary Pathology, 2011
- Lentigines, nevi, and melanomas2010
- The Histologic and Epidemiologic Bases for Prognostic Considerations in Canine Melanocytic NeoplasiaVeterinary Pathology, 2006
- Melanocytic Tumors2005
- N-ras Mutations in Canine Malignant MelanomasThe Veterinary Journal, 2003
- Expression and Significance of p53, Rb, p21/waf-1, p16/ink-4a, and PTEN Tumor Suppressors in Canine MelanomaVeterinary Pathology, 2002
- Metallothionein Expression in Canine and Feline Mammary and Melanotic TumoursJournal of Comparative Pathology, 2001